A significant advance in cancer study is occurring with the use of nanobodies to re-engage mutated p53. This essential cancer protector protein is frequently inactivated in various types of malignancies, resulting https://bookmarkswing.com/story23736823/mini-antibodies-restore-the-p53-protein-the-promising-hope-for-cancer-management